These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27617403)

  • 1. Hepatitis B core antigen upregulates B7-H1 on dendritic cells by activating the AKT/ERK/P38 pathway: a possible mechanism of hepatitis B virus persistence.
    Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Gao YT; Jiang Y; Gao YQ
    Lab Invest; 2016 Nov; 96(11):1156-1164. PubMed ID: 27617403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBcAg induces PD-1 upregulation on CD4+T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients.
    Li M; Sun XH; Zhu XJ; Jin SG; Zeng ZJ; Zhou ZH; Yu Z; Gao YQ
    Lab Invest; 2012 Feb; 92(2):295-304. PubMed ID: 22042085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B.
    Chen L; Zhang Z; Chen W; Zhang Z; Li Y; Shi M; Zhang J; Chen L; Wang S; Wang FS
    J Immunol; 2007 May; 178(10):6634-41. PubMed ID: 17475895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of human B7 homolog 1 expression in patients with hepatitis B virus infection.
    Zhang WJ; Xie HY; Duan X; Wan YL; Peng CH; Shi SH; Su R; Zheng ZH; Pan LL; Zhou L; Zheng SS
    World J Gastroenterol; 2012 Jul; 18(28):3681-95. PubMed ID: 22851860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expressions and significance of B7-H1 and programmed death-1 in lymphocytes from patients with chronic hepatitis B virus infection].
    Li YG; Chen LE; Chen GF; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Oct; 15(10):738-41. PubMed ID: 17963598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamic changes of B7-H1 expression on mDCs and T cells in chronic hepatitis B patients treated with PEG-IFN alpha-2a].
    Li YG; Chen LE; Chen GF; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):421-4. PubMed ID: 18578991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels.
    Geng L; Jiang G; Fang Y; Dong S; Xie H; Chen Y; Shen M; Zheng S
    J Viral Hepat; 2006 Nov; 13(11):725-33. PubMed ID: 17052271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection.
    Wei MJ; Pan XN; Wei KP; Li XH; Liu XL; Zhang XM; Jiang YL; Zhang CY; Shen JK
    Int Immunopharmacol; 2015 Aug; 27(2):238-43. PubMed ID: 26118632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recombinant HBcAg promotes secretion of IL-15 in myeloid dendritic cells via p38MAPK signaling pathway].
    Zhang X; Zhou Z; Li M; Gao Y; Sun X; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):289-294. PubMed ID: 28274303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection.
    Li M; Zhou ZH; Sun XH; Zhang X; Zhu XJ; Jin SG; Jiang Y; Gao YT; Li CZ; Gao YQ
    Hepatol Int; 2016 Jul; 10(4):594-601. PubMed ID: 26924524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.
    Jiang W
    Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
    Evans A; Riva A; Cooksley H; Phillips S; Puranik S; Nathwani A; Brett S; Chokshi S; Naoumov NV
    Hepatology; 2008 Sep; 48(3):759-69. PubMed ID: 18697210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
    Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment.
    Zhang JY; Song CH; Shi F; Zhang Z; Fu JL; Wang FS
    PLoS One; 2010 Nov; 5(11):e13869. PubMed ID: 21079784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of B7-H1 on peripheral blood mononuclear cells from chronic hepatitis B patients].
    Xie ZY; Chen YW; Fu XL; Yang CY; Wu YZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1635-7. PubMed ID: 18024277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crucial roles of B7-H1 and B7-DC expressed on mesenteric lymph node dendritic cells in the generation of antigen-specific CD4+Foxp3+ regulatory T cells in the establishment of oral tolerance.
    Fukaya T; Takagi H; Sato Y; Sato K; Eizumi K; Taya H; Shin T; Chen L; Dong C; Azuma M; Yagita H; Malissen B; Sato K
    Blood; 2010 Sep; 116(13):2266-76. PubMed ID: 20574047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets.
    Karakhanova S; Meisel S; Ring S; Mahnke K; Enk AH
    Eur J Immunol; 2010 Jan; 40(1):254-66. PubMed ID: 19830728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment.
    Xia J; Huang R; Chen Y; Liu Y; Wang J; Yan X; Zhang Z; Wu C
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1180-1187. PubMed ID: 32363582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.